Analystreport

Horizon Therapeutics Public Limited (NASDAQ: HZNP) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.

Horizon Therapeutics Public Limited Company - Ordinary Shares  (HZNP) 
Last horizon therapeutics public limited company - ordinary shares earnings: 2/26 07:00 am Check Earnings Report